| abstract |
The present invention provides a method of modulating the activity of a farnesoid X receptor (FXR)-like compound using a compound of formula (I) or (II). In particular, the invention provides the use of a compound of formula (I) or (II), or a stereoisomer, enantiomer or pharmaceutically acceptable salt thereof, for the treatment or prevention of liver and gastrointestinal disorders. |